37
Participants
Start Date
November 21, 2016
Primary Completion Date
July 31, 2024
Study Completion Date
January 31, 2025
Placebo Infusion
In addition to the standard of care provided to all patients with traumatic brain injury, subjects assigned to the placebo control group will undergo a sham bone marrow harvest and receive a placebo infusion of saline.
Autologous BMMNC Infusion
In addition to the standard of care provided to all patients with traumatic brain injury, subjects assigned to the BMMNC treatment group will undergo a bone marrow harvest and then receive an autologous stem cell infusion.
The University of Texas Health Science Center at Houston, Houston
United States Department of Defense
FED
U.S. Army Medical Research and Development Command
FED
The University of Texas Health Science Center, Houston
OTHER